Capital Management’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-700
| Closed | -$245K | – | 73 |
|
|
2025
Q4 | $245K | Hold |
700
| – | – | 0.04% | 63 |
|
|
2025
Q3 | $226K | Hold |
700
| – | – | 0.04% | 74 |
|
|
2025
Q2 | $272K | Hold |
700
| – | – | 0.05% | 64 |
|
|
2025
Q1 | $304K | Hold |
700
| – | – | 0.05% | 61 |
|
|
2024
Q4 | $258K | Hold |
700
| – | – | 0.05% | 68 |
|
|
2024
Q3 | $364K | Sell |
700
-60
| -8% | -$32.1K | 0.06% | 53 |
|
|
2024
Q2 | $412K | Hold |
760
| – | – | 0.08% | 51 |
|
|
2024
Q1 | $394K | Hold |
760
| – | – | 0.08% | 54 |
|
|
2023
Q4 | $358K | Hold |
760
| – | – | 0.07% | 54 |
|
|
2023
Q3 | $331K | Hold |
760
| – | – | 0.07% | 52 |
|
|
2023
Q2 | $338K | Hold |
760
| – | – | 0.07% | 52 |
|
|
2023
Q1 | $349K | Hold |
760
| – | – | 0.08% | 49 |
|
|
2022
Q4 | $390K | Hold |
760
| – | – | 0.1% | 52 |
|
|
2022
Q3 | $345K | Hold |
760
| – | – | 0.1% | 54 |
|
|
2022
Q2 | $367K | Hold |
760
| – | – | 0.09% | 54 |
|
|
2022
Q1 | $373K | Sell |
760
-1
| -0.1% | -$457 | 0.08% | 57 |
|
|
2021
Q4 | $353K | Hold |
761
| – | – | 0.07% | 63 |
|
|
2021
Q3 | $284K | Buy |
761
+11
| +1% | +$4.18K | 0.06% | 69 |
|
|
2021
Q2 | $286K | Hold |
750
| – | – | 0.06% | 68 |
|
|
2021
Q1 | $269K | Hold |
750
| – | – | 0.06% | 66 |
|
|
2020
Q4 | $241K | Hold |
750
| – | – | 0.07% | 66 |
|
|
2020
Q3 | $201K | Buy |
+750
| New | +$202K | 0.06% | 69 |
|
|
2020
Q1 | – | Sell |
-750
| Closed | -$227K | – | 77 |
|
|
2019
Q4 | $227K | Buy |
+750
| New | +$206K | 0.06% | 78 |
|
|
2019
Q3 | – | Sell |
-750
| Closed | -$212K | – | 82 |
|
|
2019
Q2 | $212K | Hold |
750
| – | – | 0.06% | 73 |
|
|
2019
Q1 | $215K | Sell |
750
-250
| -25% | -$72.3K | 0.06% | 77 |
|
|
2018
Q4 | $263K | Hold |
1,000
| – | – | 0.08% | 68 |
|
|
2018
Q3 | $274K | Hold |
1,000
| – | – | 0.07% | 69 |
|
|
2018
Q2 | $238K | Hold |
1,000
| – | – | 0.06% | 69 |
|
|
2018
Q1 | $220K | Sell |
1,000
-200
| -17% | -$47K | 0.06% | 83 |
|
|
2017
Q4 | $270K | Hold |
1,200
| – | – | 0.07% | 75 |
|
|
2017
Q3 | $228K | Hold |
1,200
| – | – | 0.07% | 83 |
|
|
2017
Q2 | $226K | Buy |
+1,200
| New | +$216K | 0.07% | 88 |
|
|
2016
Q3 | – | Sell |
-1,568
| Closed | -$206K | – | 92 |
|
|
2016
Q2 | $206K | Hold |
1,568
| – | – | 0.08% | 85 |
|
|
2016
Q1 | $218K | Hold |
1,568
| – | – | 0.08% | 79 |
|
|
2015
Q4 | $219K | Hold |
1,568
| – | – | 0.08% | 80 |
|
|
2015
Q3 | $220K | Hold |
1,568
| – | – | 0.09% | 75 |
|
|
2015
Q2 | $257K | Hold |
1,568
| – | – | 0.09% | 78 |
|
|
2015
Q1 | $242K | Buy |
+1,568
| New | +$223K | 0.08% | 77 |
|
Other funds holding ELV
Capital Management's ELV Position: Q1 2026 in Review
Capital Management sold out of Elevance Health (ELV) in Q1 2026, closing a stake of 700 shares — an estimated $245K sold.
Capital Management first reported a position in ELV in Q1 2015 and held it in 38 quarters. The position peaked at $412K in Q2 2024. 1,470 funds tracked by Wall St. Rank hold ELV as of Q1 2026.
- Capital Management reported no remaining Elevance Health position as of Q1 2026 after selling out during the quarter.
- Capital Management sold 700 Elevance Health shares in Q1 2026, an estimated $245K.
- Capital Management first reported a position in Elevance Health in Q1 2015 and held it in 38 quarters.
- Capital Management's Elevance Health position peaked at $412K in Q2 2024.
- 1,470 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.
Based on Capital Management's 13F filing for Q1 2026, filed 23 Apr 2026.